截至2026年2月，7家覆盖睿思飞的机构中，买入或增持观点占比43%，持有占比43%，减持或卖出占比 14%，评级整体稳定。盈利预测显示积极迹象：机构预测2025年第四季度每股收益同比增长1100%，净 利润同比增长351.19%，营业收入同比增长7.59%，反映市场对业务改善的预期。不过，当前市盈率 (TTM)为负值(-19.61)，表明公司仍处亏损阶段，需关注后续盈利兑现情况。 经济观察网近7天，睿思飞(RSKD.N)股价呈现波动上涨态势，区间涨跌幅为4.88%，振幅达10.23%。具 体来看，2月5日收盘价4.14美元(单日跌3.72%)，2月6日回升至4.29美元(涨3.62%)，2月9日进一步上涨至 4.49美元(涨4.66%)，2月10日收于4.51美元(涨0.45%)。成交方面，区间成交额约1176.53万美元，换手率 较低，显示市场交易活跃度温和。股价波动主要受整体软件服务板块情绪影响，但无公司特定事件驱 动。 机构观点 以上内容基于公开资料整理，不构成投资建议。 ...

机构观点 经济观察网近7天(2026年02月05日至02月10日)，奥德赛海洋探索(OMEX.OQ)股价呈现剧烈波动。02月 05日股价大幅下跌16.95%至1.47美元，单日成交额达194万美元；02月06日强势反弹10.88%至1.63美 元，成交额133万美元；02月09日继续上涨5.52%至1.72美元；02月10日微跌0.58%至1.71美元。区间振 幅为15.82%，成交总量超280万股，市场交投活跃。 当前有1家机构对奥德赛海洋探索给出目标均价7.50美元，较最新收盘价1.71美元存在显著差距，机构观 点凸显长期预期。 以上内容基于公开资料整理，不构成投资建议。 ...

业绩经营情况 该公司最新财报数据显示其营业收入为463万美元，净利润为-372万美元，每股收益为-0.41美元。 经济观察网 根据公开信息，截至2026年1月8日，UT斯达康（UTSI.US）近期股价出现波动，但暂无公 开披露的即将发生的重大事件。该公司最新财报数据显示其营业收入为463万美元，净利润为-372万美 元，每股收益为-0.41美元。机构评级方面，目前暂无机构对该股给出投资建议。 机构观点 股票近期走势 机构评级方面，目前暂无机构对该股给出投资建议。 根据公开信息，截至2026年1月8日，UT斯达康（UTSI.US）近期股价出现波动，但暂无公开披露的即 将发生的重大事件。 以上内容基于公开资料整理，不构成投资建议。 ...

（文章来源：证券日报） 证券日报网讯 2月11日，长江电力在互动平台回答投资者提问时表示，当前股价波动受多重因素综合影 响，包括宏观经济环境、市场情绪、行业周期性变化以及投资者对政策预期的动态调整。关于电力行业 政策调整对上网电价及公司业绩的影响，需结合具体政策内容、执行细则及公司实际运营情况综合研 判。 ...

Core Viewpoint - The stock price of Huali Group is influenced by its independent fundamentals and market sentiment, rather than being directly affected by Under Armour's performance [1] Recent Stock Performance - Huali Group is a leading global sneaker manufacturer with clients including Nike, Deckers (including UGG and Hoka), On, and Puma, with Under Armour being just one of its clients. As of the 2025 semi-annual report, the revenue contribution from the top five clients has decreased to 71.88%, indicating enhanced client diversification [2] - In the first half of 2025, the company's revenue grew by 10.36% year-on-year, while net profit declined by 11.06%, primarily due to new factory capacity ramp-up, fluctuations in orders from some existing clients, and uncertainties in international trade policies. The impact of Under Armour's orders on Huali Group's overall business is limited, making its revenue fluctuations relatively controllable [2] Recent Events - Under Armour reported a 5% year-on-year decline in revenue for the third quarter of fiscal year 2026 (ending December 31, 2025), with a 10% drop in North America but a 3% growth in international markets. The recent stock price fluctuations (e.g., a 10.70% drop on February 10, 2026) mainly reflect its own growth challenges and a weak North American market. Under Armour is undergoing a transformation by streamlining its product line and focusing on the Chinese market, but short-term performance remains under pressure [3] Company Fundamentals - In November 2025, the controlling shareholder, Junyao Group, received a warning letter for disproportionate share reduction, having cashed out 1.86 billion yuan, raising concerns about governance structure. The stock price fell from an average reduction price of 55.66 yuan to 49.49 yuan on February 11, 2026, a decline of approximately 9.8% [4] - The company's fundamentals are under short-term pressure, with a 20.73% year-on-year decline in net profit attributable to the parent company in the third quarter of 2025, and a 4.8 percentage point drop in gross margin, although there was a 1.1 percentage point improvement quarter-on-quarter, indicating initial success in ramping up new factory capacity [4] Financial Situation - Since February 2026, there has been a net outflow of major funds, while retail investor funds have seen a net inflow, reflecting short-term sentiment being affected by events [5] Industry and Risk Analysis - In the sports footwear and apparel supply chain, brand performance fluctuations may indirectly impact suppliers' order expectations. However, Huali Group's core risks are more concentrated on its own capacity ramp-up efficiency, tariff policies, and actions of major shareholders. Currently, there is no significant correlation between the stock price performance of Huali Group and Under Armour, as both are primarily driven by internal factors [6]

Price Movement - The stock price of Xili Technology (688616) has shown volatility over the past week, with an overall increase of 1.93% [1] - The highest price during this period was 13.94 yuan on February 9, while the lowest was 13.18 yuan on February 6, resulting in a fluctuation of 5.64% [1] Fund Flow - On February 10, the net outflow of main funds was 974,600 yuan, accounting for 3.51% of the total transaction amount [2] - Retail investors saw a net inflow of 2,245,900 yuan, while speculative funds experienced a net outflow of 1,271,300 yuan [2] - The margin financing and securities lending balance was 72,281,600 yuan on February 9, down 2.12% from the previous day [2] Financial Report Analysis - For the first three quarters of 2025, Xili Technology reported a main revenue of 403 million yuan, a year-on-year decrease of 14.19% [3] - The net profit attributable to the parent company was 66.34 million yuan, down 11.48% year-on-year, while the net profit excluding non-recurring items was 62.19 million yuan, a decrease of 1.85% [3] - In the third quarter of 2025, the revenue was 152 million yuan, reflecting a year-on-year decline of 22.24%, and the net profit was 25.99 million yuan, down 31.37% year-on-year [3] - The company's debt ratio stands at 18.24%, and the gross profit margin is 29.56% [3]

Core Viewpoint - The company is expected to report a net loss of approximately 19 million yuan for the fiscal year 2025, with revenues around 170 million yuan, which may lead to a delisting risk warning if confirmed by the audited annual report [1][2]. Financial Performance - The company announced a projected net profit attributable to shareholders of approximately -19 million yuan for 2025, with a net profit of about -24.5 million yuan after excluding non-recurring gains and losses [2]. - The anticipated annual revenue is around 170 million yuan, and after excluding non-main business income, it is expected to be about 164 million yuan, which is below 300 million yuan [2]. Company Status - The company disclosed a plan on September 19, 2025, to reduce its holdings of shares repurchased in 2024 by up to 10.48 million shares within six months [3]. - As of February 4, 2026, the share reduction plan is still in progress, and the company will continue to promote the sale of the remaining repurchased shares [3]. Stock Performance - On February 10, 2026, the stock price of Jiyou Co., Ltd. (603429) closed at 10.99 yuan per share, with a daily increase of 2.04% and a trading volume of 63.9649 million yuan [4]. - Year-to-date, the company's stock price has risen by 10.90%, with a 5-day increase of 20.24% [4]. - However, there was a net outflow of 1.2874 million yuan in major funds on that day [4]. Recent Events of Interest - The company disclosed two pending lawsuits in its annual performance loss announcement, with a total amount involved of approximately 5.45 million yuan, which may impact the company's financial data [5]. Business and Technical Development - The company's traditional cigarette packaging printing business continues to decline, and it is actively transitioning to the energy storage and new materials sector [6]. - However, this new business is still in the investment phase and is unlikely to provide substantial support to performance in the short term [6].

证券日报网讯 2月10日，先锋精科在互动平台回答投资者提问时表示，公司股价受宏观经济环境、市场 情绪等多重因素综合影响，具有不确定性。目前公司经营状况正常，并严格按照相关规定及时履行信息 披露义务。公司将持续提升经营质量、坚持规范运作、加强与投资者的沟通，敬请投资者理性看待股价 波动。 （文章来源：证券日报） ...

2026年2月10日，*ST精伦（sh600355）触及跌停，跌停价1.38元，涨幅-5.07%，总市值6.45亿元，流通 市值6.45亿元，截止发稿，总成交额21.92万元。 声明：市场有风险，投资需谨慎。本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 根据喜娜AI异动分析，*ST精伦跌停原因可能如下，业绩亏损+市场交易+股价波动： 1、业绩亏损压 力：2026年1月28日业绩预告显示2025年报亏损小幅增加，归母净利润 -4550万~ -3950万。业绩亏损增 加对公司股价形成一定压力，投资者对公司的盈利预期降低，进而影响股价表现，这是导致跌停的重要 因素。 2、市场交易因素：2026年2月6日发生4笔大宗交易，虽然折溢率为0表明交易价格与市场价格一 致 ...

Core Viewpoint - Omnicell, Inc. has set a new price target of $49, indicating a potential upside despite recent challenges in earnings performance [1][6] Financial Performance - The stock price dropped significantly from a previous close of $46.69 to a last traded price of $38.38 following a disappointing earnings announcement [2] - Omnicell reported earnings per share (EPS) of $0.40, missing the consensus estimate of $0.47 by $0.07 [2] - Revenue for the quarter was $313.98 million, slightly exceeding analysts' expectations of $313.36 million, representing a 2.3% increase year-over-year [3] Guidance and Outlook - The company has raised its guidance for Q1 2026 to an EPS range of $0.26 to $0.36 and for FY 2026 to an EPS range of $1.65 to $1.85, indicating a positive outlook [4][6] - Despite a 16.30% decrease in stock price on the day of the earnings announcement, the new price target suggests potential growth for Omnicell [4][5] Market Position - Omnicell operates in a competitive market with key players such as McKesson and Cardinal Health [1] - The company's market capitalization is approximately $1.80 billion, with a trading volume of 2,835,483 shares [5]